Recent Headlines
Within Biotechnology
Baxa Corporation Expands Headquarters Facilities
Baxa Corporation announces the addition of a new building to its corporate headquarters in Metro Denver. The expansion provides a 15,000 square-foot facility accommodating the sales, marketing and technical support operations for the medical device manufacturer. Two years after the company built a state-of-the-art production facility in Englewood, Colorado, unprecedented business growth constrained the office and administration space. - February 27, 2005 - Baxa Corporation
"Understanding USP 797" and "Environmental Controls for Sterile Compounding" Technical Papers are Now Posted on PublicRelationsNewsroom.com
Two technical papers produced by Baxa Corporation – “Understanding USP 797” and “Environmental Controls for Sterile Compounding” are now posted for media and professional access on PublicRelationsNewsroom.com. The American Society of Health-System Pharmacists (ASHP) released USP 797 in January 2004 and the National Institute for Occupational Safety and Health (NIOSH) published its 2004 alert on the health risks posed to those working with hazardous drugs. - January 30, 2005 - Baxa Corporation